Source: Health Products and Food Branch (CA) Revision Year: 2006
RAMACE (ramipril).
1.25 mg, 2.5 mg, 5.0 mg and 10.0 mg Tablets.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
sanofi-aventis Canada Inc., 2150 St. Elzear Blvd. West, Laval, Québec H7L 4A8 107870 |
Date of revision:
October 24, 2006 |
| Drug | Countries | |
|---|---|---|
| RAMACE | Australia, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
